Cutaneous autoimmune diseases during COVID-19 pandemic

J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e667-e670. doi: 10.1111/jdv.16753. Epub 2020 Jul 2.

Abstract

The pandemic of infection with the severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing the atypical pneumonia coronavirus disease 19 (Covid‐2019) has become a global health emergency. In parallel with the spread of the infection, there are new information on cutaneous involvement reminiscent to autoimmune diseases and concerns about the risk of disease and management of patients with cutaneous autoimmunity under immunosuppression.

Publication types

  • Letter

MeSH terms

  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / epidemiology
  • Autoimmune Diseases / virology*
  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / virology*
  • SARS-CoV-2
  • Skin Diseases / drug therapy
  • Skin Diseases / epidemiology
  • Skin Diseases / immunology*
  • Skin Diseases / virology*

Substances

  • Immunosuppressive Agents